SE442480B - Forfarande for framstellning av en glukoshaltig infusionslosning - Google Patents

Forfarande for framstellning av en glukoshaltig infusionslosning

Info

Publication number
SE442480B
SE442480B SE7714359A SE7714359A SE442480B SE 442480 B SE442480 B SE 442480B SE 7714359 A SE7714359 A SE 7714359A SE 7714359 A SE7714359 A SE 7714359A SE 442480 B SE442480 B SE 442480B
Authority
SE
Sweden
Prior art keywords
glucose
solution
quinine
bradykinin
infusion
Prior art date
Application number
SE7714359A
Other languages
English (en)
Swedish (sv)
Other versions
SE7714359L (sv
Inventor
G Dietze
M Wicklmayr
Original Assignee
Thera Ges Fuer Patente
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thera Ges Fuer Patente filed Critical Thera Ges Fuer Patente
Publication of SE7714359L publication Critical patent/SE7714359L/xx
Publication of SE442480B publication Critical patent/SE442480B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7714359A 1976-12-17 1977-12-16 Forfarande for framstellning av en glukoshaltig infusionslosning SE442480B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2657381A DE2657381C2 (de) 1976-12-17 1976-12-17 Glucosehaltige Infusionslösung

Publications (2)

Publication Number Publication Date
SE7714359L SE7714359L (sv) 1978-06-18
SE442480B true SE442480B (sv) 1986-01-13

Family

ID=5995850

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7714359A SE442480B (sv) 1976-12-17 1977-12-16 Forfarande for framstellning av en glukoshaltig infusionslosning

Country Status (12)

Country Link
US (1) US4152425A (de)
JP (1) JPS5914006B2 (de)
AT (1) ATA904977A (de)
AU (1) AU517454B2 (de)
CA (1) CA1077845A (de)
CH (1) CH638400A5 (de)
DE (1) DE2657381C2 (de)
FR (1) FR2374043A1 (de)
GB (1) GB1545743A (de)
IE (1) IE46281B1 (de)
NL (1) NL7713961A (de)
SE (1) SE442480B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH639247A5 (de) * 1979-01-23 1983-11-15 Thera Ges Fuer Patente Aminosaeuren und mineralsalze enthaltende infusionsloesung.
US5385940A (en) * 1992-11-05 1995-01-31 The General Hospital Corporation Treatment of stroke with nitric-oxide releasing compounds
US20020076782A1 (en) * 1996-07-05 2002-06-20 John P.N. Rosazza Purified nitric oxide synthase

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE352533B (de) * 1967-10-20 1973-01-08 Sandoz Ag
DE2357507C3 (de) * 1973-11-17 1980-07-31 Bayer Ag, 5090 Leverkusen Mittel zur Fertilitätssteigemng
DE2657382A1 (de) * 1976-12-17 1978-06-29 Thera Ges Fuer Patente Orales antidiabetikmittel

Also Published As

Publication number Publication date
SE7714359L (sv) 1978-06-18
AU517454B2 (en) 1981-07-30
DE2657381A1 (de) 1978-06-29
US4152425A (en) 1979-05-01
JPS5914006B2 (ja) 1984-04-02
AU3175877A (en) 1979-06-28
JPS5386010A (en) 1978-07-29
CH638400A5 (de) 1983-09-30
IE46281L (en) 1978-06-17
DE2657381C2 (de) 1982-03-25
CA1077845A (en) 1980-05-20
ATA904977A (de) 1979-05-15
IE46281B1 (en) 1983-04-20
FR2374043B1 (de) 1982-06-11
NL7713961A (nl) 1978-06-20
GB1545743A (en) 1979-05-16
FR2374043A1 (fr) 1978-07-13

Similar Documents

Publication Publication Date Title
Domschke et al. Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects.
US9668994B2 (en) Methods and compositions for increasing the anaerobic working capacity in tissues
AU624595B2 (en) Method for treating and preventing secondary effects of hyperinsulinemia and for treating type 2 diabetes, obesity and hyperlipidemia by application of insulin-like growth factor (IGF I)
AUSTGEN et al. The effects of glutamine-enriched total parenteral nutrition on tumor growth and host tissues
Pentecost et al. Controlled trial of intravenous glucose, potassium, and insulin in acute myocardial infarction
JPH09512552A (ja) 腎疾患および不全の治療方法ならびに組成物
JP2014065740A (ja) 高齢者の骨格筋量減少を防止又は改善するためのアミノ酸含有組成物
NL8101182A (nl) Voedingspreparaten, alsmede toedieningswijze ervan.
CN108721596B (zh) 一种复方氨基酸维生素注射液及其应用
Gore et al. Relative influence of glucose and insulin on peripheral amino acid metabolism in severely burned patients
US5276018A (en) Composition comprising amino acids and methods for decreasing muscle breakdown
EP0666739B1 (de) Intravenöse lösung, die den protein - und wasserverlust im körper reduziert
KR20100015922A (ko) 암 환자용 수액 제제
Gil et al. Splanchnic substrate balance in malnourished patients during parenteral nutrition
SE442480B (sv) Forfarande for framstellning av en glukoshaltig infusionslosning
Valarini et al. Anabolic effects of insulin and amino acids in promoting nitrogen accretion in postoperative patients
CA1334575C (en) Substitution fluid preparation comprising 3-hydroxybutyric acid (beta-hydroxybutyric acid) and its salts
WO2020043708A1 (en) Lactate-protected hypoglycemia to treat glycolysis dependent pathological conditions, in particular cancer
Cuthbertson et al. Nutrition in the post-traumatic period
JPS5923291B2 (ja) アミノ酸および無機塩を含有する注入液
Beal et al. The metabolism of fructose in man
WO1982003552A1 (en) Improved solution for parenteral nutrition
Robscheit-Robbins et al. Gelatin—Its usefulness and toxicity: Blood protein production impaired by continued gelatin by vein
Gazzaniga et al. Endogenous caloric sources and nitrogen balance: regulation in postoperative patients
JP3429327B2 (ja) 癌用アミノ酸輸液剤

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7714359-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7714359-2

Format of ref document f/p: F